Gut health formulation is entering a new phase. For most of the last five to six years, the category was dominated almost entirely by probiotics, with CFU count as the primary selling point. Coverage of the Specialty Food Association’s Summer Fancy Food Show 2026, reported by FoodNavigator-USA, shows brands now moving into adjacent ingredient categories: postbiotics, prebiotic fiber, A2 dairy protein, fermented vegetable extracts, and fennel-based botanicals.

This article summarises the key formulation and sourcing implications for R&D and procurement teams evaluating this shift.

What’s Changing in the Gut Health Category

The expansion beyond single-strain probiotics is driven partly by formulation constraints. Live microorganisms require tight cold-chain control and have comparatively short shelf lives. Postbiotics and prebiotic fibers offer formulators more flexibility because they don’t depend on maintaining live cultures through processing, distribution, and shelf storage — while still contributing to the same functional category.

Clarifying the Terminology: Probiotics, Prebiotics, Postbiotics, Synbiotics

Precise terminology matters when briefing suppliers or writing specs:

These distinctions directly affect storage conditions, processing temperatures, and finished-product shelf life.

Ingredient Categories Highlighted in the Report

The show coverage pointed to three specific categories gaining formulation traction:

Spec Checklist Before Formulating

Before substituting or adding these ingredients into an existing formulation, verify the following with the supplier:

Supply Chain Implications

What’s often underestimated is that these four ingredient categories originate from entirely separate supply chains — dairy processing, microbial fermentation, botanical extraction, and fiber processing. Manufacturers formulating across multiple categories simultaneously need to manage a broader supplier base and accept that lead times will not be uniform across ingredients. Working with a partner that understands specs across multiple ingredient categories, and carries inventory positioned for uneven demand, reduces the risk of stockouts during periods of fast-shifting demand.

A Note on Labeling and Claims

When communicating with marketing or regulatory teams, it’s important to separate ingredient function (e.g. a prebiotic fiber serving as a substrate for gut microbiota) from finished-product health benefit claims, which require regulatory review specific to each market before appearing on labels or marketing materials.

How DIC supports this

DIC maintains an isolated pharma-grade warehouse for ingredients requiring controlled humidity and temperature, alongside a VMI (Vendor Managed Inventory) program that allows manufacturers to manage multiple ingredient categories without carrying excess stock. If your team is evaluating gut-health ingredients for a new formulation, reach out to our team for spec sheets or sourcing guidance.

This analysis is also available in ภาษาไทย · Tiếng Việt ภาษาไทย →Tiếng Việt →